Case Studies

Developing scenario-based 5-year commercial assessment across Canada, France, Germany, the UK and the US

01/01/2023

Author:

Sarah Bailey
About the Author

Article Tags

Chemotherapy HTA HTA Process Oncology Pricing

Share this article

Related articles

Webinar
05.11.2026
PICO Planning for HTA | On-Demand Webinar | Remap

Predicting PICO requirements can help pharmaceutical manufacturers anticipate the populations, compa...

Read more
Articles
02.11.2026
JCA Evidence Gaps: Meeting National Payer Needs

Introduction The EU Joint Clinical Assessment (JCA) was introduced to reduce duplication and establi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch